193 related articles for article (PubMed ID: 23449978)
1. The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells.
Pal M; Koul S; Koul HK
J Biol Chem; 2013 Apr; 288(17):12222-31. PubMed ID: 23449978
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor SPDEF suppresses prostate tumor metastasis.
Steffan JJ; Koul S; Meacham RB; Koul HK
J Biol Chem; 2012 Aug; 287(35):29968-78. PubMed ID: 22761428
[TBL] [Abstract][Full Text] [Related]
3. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
[TBL] [Abstract][Full Text] [Related]
4. SPDEF: a molecular switch for E-cadherin expression that promotes prostate cancer metastasis.
Osisami M; Keller ET
Asian J Androl; 2013 Sep; 15(5):584-5. PubMed ID: 23708459
[No Abstract] [Full Text] [Related]
5. A tight junction between E-Cadherin and the prostate tumor suppressor SPDEF.
Coppola V; Bonci D
Asian J Androl; 2013 Jul; 15(4):449-50. PubMed ID: 23708463
[No Abstract] [Full Text] [Related]
6. GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration.
Tamura RE; Paccez JD; Duncan KC; Morale MG; Simabuco FM; Dillon S; Correa RG; Gu X; Libermann TA; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13865-79. PubMed ID: 26885618
[TBL] [Abstract][Full Text] [Related]
7. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
[TBL] [Abstract][Full Text] [Related]
8. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
[TBL] [Abstract][Full Text] [Related]
9. SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells.
Noah TK; Kazanjian A; Whitsett J; Shroyer NF
Exp Cell Res; 2010 Feb; 316(3):452-65. PubMed ID: 19786015
[TBL] [Abstract][Full Text] [Related]
10. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.
Vatanmakanian M; Steffan JJ; Koul S; Ochoa AC; Chaturvedi LS; Koul HK
Front Endocrinol (Lausanne); 2023; 14():1156120. PubMed ID: 37900138
[TBL] [Abstract][Full Text] [Related]
11. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
[TBL] [Abstract][Full Text] [Related]
12. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
Brett A; Pandey S; Fraizer G
Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2.
Tsai YC; Chen WY; Abou-Kheir W; Zeng T; Yin JJ; Bahmad H; Lee YC; Liu YN
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1717-1727. PubMed ID: 29477409
[TBL] [Abstract][Full Text] [Related]
15. High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy.
Haller AC; Tan W; Payne-Ondracek R; Underwood W; Tian L; Morrison C; Li F
Prostate; 2014 May; 74(5):509-19. PubMed ID: 24375440
[TBL] [Abstract][Full Text] [Related]
16. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.
Noah TK; Lo YH; Price A; Chen G; King E; Washington MK; Aronow BJ; Shroyer NF
Gastroenterology; 2013 May; 144(5):1012-1023.e6. PubMed ID: 23376423
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
18. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
Chen WY; Tsai YC; Yeh HL; Suau F; Jiang KC; Shao AN; Huang J; Liu YN
Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811384
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
20. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
